FDA Approves New Opioid Dsuvia Despite Opposition

FDA Approves New Opioid

On Friday, the United States Food and Drug Administration (FDA) approved a new opioid despite strong opposition to the new drug. The military asked that the FDA approve the drug.

According to an NBC News report, the FDA approved a powerful new drug, Dsuvia, amidst strong criticism that the governing body did not follow its own process during the approval. The drug, called sufentanil generically, goes under the tongue to treat intense, acute pain, and it was designed to use in battlefields and emergencies. It is ten times more powerful than fentanyl and 1,000 times more potent than morphine, and some healthcare providers feel significant concern.

AcelRx makes the 3-millimeter-wide tablet. The drug cannot be used for more than 72 hours and must be administered by a health care provider. Plus, it cannot be used at home.

On October 12, the new drug went in front of the panel, which voted 10-3 on Friday to recommend approval of the potent opioid, NPR reported.

Click here to continue and read more...

Share on Google Plus
    Blogger Comment
    Facebook Comment

0 comments :

Post a Comment